Stryker Co. (NYSE:SYK) Forecasted to Earn Q1 2020 Earnings of $2.07 Per Share – Riverton Roll

Stryker Co. (NYSE:SYK) Research analysts at Oppenheimer issued their Q1 2020 earnings per share (EPS) estimates for Stryker in a research report issued on Friday, January 10th, according to Zacks Investment Research. Oppenheimer analyst S. Lichtman expects that the medical technology company will post earnings per share of $2.07 for the quarter. Oppenheimer also issued estimates for Strykers Q2 2020 earnings at $2.20 EPS, Q3 2020 earnings at $2.12 EPS, Q4 2020 earnings at $2.65 EPS and FY2021 earnings at $9.95 EPS.

Other equities research analysts have also recently issued research reports about the stock. ValuEngine cut shares of Stryker from a buy rating to a hold rating in a report on Wednesday, October 2nd. Morgan Stanley increased their price target on shares of Stryker from $230.00 to $242.00 and gave the company an overweight rating in a report on Tuesday, December 17th. Piper Jaffray Companies cut shares of Stryker from an overweight rating to a neutral rating and set a $210.00 price target on the stock. in a report on Tuesday, January 7th. Zacks Investment Research upgraded shares of Stryker from a hold rating to a buy rating and set a $215.00 target price on the stock in a report on Thursday, November 28th. Finally, Robert W. Baird raised their target price on shares of Stryker from $239.00 to $242.00 and gave the stock an outperform rating in a report on Wednesday, October 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Stryker currently has an average rating of Buy and an average target price of $222.16.

SYK stock opened at $212.17 on Monday. Stryker has a 1 year low of $160.79 and a 1 year high of $223.45. The firm has a 50-day moving average of $207.23 and a 200 day moving average of $211.09. The company has a market cap of $78.36 billion, a P/E ratio of 23.52, a PEG ratio of 2.33 and a beta of 0.76. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.18 and a quick ratio of 1.35.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, October 29th. The medical technology company reported $1.91 earnings per share (EPS) for the quarter, topping the Zacks consensus estimate of $1.90 by $0.01. Stryker had a net margin of 23.55% and a return on equity of 25.33%. The company had revenue of $3.59 billion during the quarter, compared to the consensus estimate of $3.58 billion. During the same period in the prior year, the firm earned $1.69 earnings per share. Strykers revenue was up 10.6% on a year-over-year basis.

Several institutional investors have recently modified their holdings of SYK. Garrett Wealth Advisory Group LLC bought a new stake in shares of Stryker during the 3rd quarter valued at $35,000. Stonebridge Capital Advisors LLC bought a new stake in shares of Stryker during the 2nd quarter valued at $39,000. Evoke Wealth LLC bought a new stake in shares of Stryker during the 3rd quarter valued at $42,000. Horan Capital Advisors LLC. bought a new stake in shares of Stryker during the 3rd quarter valued at $43,000. Finally, Institutional & Family Asset Management LLC raised its position in shares of Stryker by 169.3% during the 3rd quarter. Institutional & Family Asset Management LLC now owns 202 shares of the medical technology companys stock valued at $44,000 after purchasing an additional 127 shares during the period. Institutional investors and hedge funds own 73.16% of the companys stock.

In other news, CEO Kevin Lobo sold 19,286 shares of Stryker stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $215.71, for a total transaction of $4,160,183.06. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Glenn S. Boehnlein sold 2,700 shares of Stryker stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $215.85, for a total transaction of $582,795.00. Following the transaction, the chief financial officer now owns 17,933 shares in the company, valued at approximately $3,870,838.05. The disclosure for this sale can be found here. Insiders sold 26,652 shares of company stock worth $5,705,481 in the last 90 days. 7.20% of the stock is currently owned by corporate insiders.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.575 dividend. The ex-dividend date is Monday, December 30th. This represents a $2.30 annualized dividend and a yield of 1.08%. This is a boost from Strykers previous quarterly dividend of $0.52. Strykers dividend payout ratio (DPR) is currently 31.46%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Stryker Co. (NYSE:SYK) Forecasted to Earn Q1 2020 Earnings of $2.07 Per Share – Riverton Roll

Categories

Archives